Brian B. Hansen
Soborg, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Effect of Orally Administered Semaglutide Versus Dulaglutide on Diabetes-Related Quality of Life in Japanese Patients with Type 2 Diabetes: The PIONEER 10 Randomized, Active-Controlled Trial.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: November 16, 2020
Evaluation of the Clinical and Economic Burden of Poor Glycemic Control Associated with Therapeutic Inertia in Patients with Type 2 Diabetes in the United States.
Journal: Advances in therapy
Published: November 29, 2019
Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: November 01, 2019
Evaluation of the Cost Per Patient Achieving Treatment Targets with Oral Semaglutide: A Short-Term Cost-Effectiveness Analysis in the United States.
Journal: Advances in therapy
Published: September 24, 2019
Orally Administered Semaglutide Versus GLP-1 RAs in Patients with Type 2 Diabetes Previously Receiving 1-2 Oral Antidiabetics: Systematic Review and Network Meta-Analysis.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: August 30, 2019
Cost-Effectiveness of Insulin Degludec/Insulin Aspart Versus Biphasic Insulin Aspart in Patients with Type 2 Diabetes from a Danish Health-Care Perspective.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: June 14, 2016
The Economic and Health-related Impact of Crohn's Disease in the United States: Evidence from a Nationally Representative Survey.
Journal: Inflammatory bowel diseases
Published: March 15, 2016
Development of a conceptual model evaluating the humanistic and economic burden of Crohn's disease: implications for patient-reported outcomes measurement and economic evaluation.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: May 20, 2015
Key data elements for use in cost-utility modeling of biological treatments for rheumatoid arthritis.
Journal: Journal of medical economics
Published: December 23, 2014
Linguistic validation into 20 languages and content validity of the rheumatoid arthritis-specific Work Productivity and Activity Impairment questionnaire.
Journal: The patient
Published: March 28, 2014
Patient-reported outcome measures for systemic lupus erythematosus clinical trials: a review of content validity, face validity and psychometric performance.
Journal: Health and quality of life outcomes
Published: March 10, 2014
Efficacy and Safety of Anti-Interleukin-20 Monoclonal Antibody in Patients With Rheumatoid Arthritis: A Randomized Phase IIa Trial.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: January 18, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026